← Back to Search

Bereavement Support Strategies for Grief After Child Loss

N/A

Recruiting

Led By Stacy Lindau, MD, MAPP

Research Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up ~6.5 months after child's death

Awards & highlights

Study Summary

This trial aims to bridge a gap in the healthcare system that leaves parents bereaved by the traumatic death of a child to find help on their own. It will test two strategies to support these families.

Who is the study for?

This trial is for parents or legal caregivers who have lost a child under 25 years old to unexpected or traumatic events, and are referred by medical examiners. Participants must be able to communicate in English or Spanish and give permission to the ME for referral. Those unable to understand these languages or under 18 cannot join.Check my eligibility

What is being tested?

The study compares two support strategies for grieving parents post-child loss: General Bereavement Support Information versus CommunityRx-Bereavement, aiming to address the healthcare system's gap in aiding families during such crises.See study design

What are the potential side effects?

Since this trial involves non-medical interventions focused on emotional and community support, traditional physical side effects associated with medications are not applicable.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ ~6.5 months after child's death

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~~6.5 months after child's death

This trial's timeline: 3 weeks for screening, Varies for treatment, and ~6.5 months after child's death for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Complicated Grief

Parent Self-efficacy for Finding Resources

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CommunityRx-Bereavement (CRx-B)Experimental Treatment1 Intervention

Group II: General Bereavement Support Information (GBSI)Active Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor

258 Previous Clinical Trials

5,187,130 Total Patients Enrolled

Patient-Centered Outcomes Research InstituteOTHER

551 Previous Clinical Trials

29,995,458 Total Patients Enrolled

University of ChicagoOTHER

1,004 Previous Clinical Trials

817,777 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots in this trial for individuals seeking treatment?

"Data posted on clinicaltrials.gov indicates that, although this medical trial was initially published on February 1st 2024 and last edited 11/11/2023, it is not currently enrolling participants. Nonetheless there are 8 other studies actively recruiting suitable candidates at present."

Answered by AI

How many sites are conducting this clinical research?

"Potential candidates for this clinical trial can be found at the Will County Coroner's Office, located in Joliet; Kane County Coroner's Office of Saint Charles; and DuPage County Coroner's Office of Wheaton. There are also 6 other sites available to recruit from."

Answered by AI